Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „abacavir“
Suchtreffer
Begriffe & Kennungen
Triumeq · 4.5 · Abacavir is metabolised by UGT (UGT2B7) and alcohol dehydrogenase; co-administration of inducers (e.g. rifampi
Eintrag öffnenTriumeq · 4.5 · Although abacavir and lamivudine are substrates of BCRP and P-gp in vitro, given the high absolute bioavailabi
Eintrag öffnenTriumeq · 4.5 · Although abacavir and lamivudine are substrates of BCRP and P-gp in vitro, given the high absolute bioavailabi
Eintrag öffnenTriumeq · 4.5 · Effect of dolutegravir, abacavir and lamivudine on the pharmacokinetics of other medicinal products
Eintrag öffnenTriumeq · 4.5 · Effect of dolutegravir, abacavir and lamivudine on the pharmacokinetics of other medicinal products
Eintrag öffnenTriumeq · 4.5 · Effect of other medicinal products on the pharmacokinetics of dolutegravir, abacavir and lamivudine
Eintrag öffnenTriumeq · 4.5 · Ethanol/Abacavir Abacavir: (0.7 g/kg single dose/600mg AUC ↑ 41% single dose) Ethanol: AUC ↔
Eintrag öffnenTriumeq · 4.5 · Ethanol/Abacavir Abacavir: (0.7 g/kg single dose/600mg AUC ↑ 41% single dose) Ethanol: AUC ↔
Eintrag öffnenTriumeq · 4.5 · In vitro, abacavir demonstrated the potential to inhibit CYP1A1 and limited potential to inhibit metabolism me
Eintrag öffnenTriumeq · 4.5 · In vitro, abacavir demonstrated the potential to inhibit CYP1A1 and limited potential to inhibit metabolism me
Eintrag öffnenTriumeq · 4.5 · Interactions between dolutegravir, abacavir, lamivudine and co-administered medical products are listed in Tab
Eintrag öffnenTriumeq · 4.5 · Interactions between dolutegravir, abacavir, lamivudine and co-administered medical products are listed in Tab
Eintrag öffnenTriumeq · 4.5 · Lopinavir+ritonavir/ Abacavir Abacavir AUC ↓ 32% Darunavir+ritonavir/ Dolutegravir ↓ No dose adjustment is nec
Eintrag öffnenTriumeq · 4.5 · Lopinavir+ritonavir/ Abacavir Abacavir AUC ↓ 32% Darunavir+ritonavir/ Dolutegravir ↓ No dose adjustment is nec
Eintrag öffnenTriumeq · 4.5 · Triumeq contains dolutegravir, abacavir and lamivudine, therefore any interactions identified for these indivi
Eintrag öffnenTriumeq · 4.5 · Triumeq contains dolutegravir, abacavir and lamivudine, therefore any interactions identified for these indivi
Eintrag öffnenTriumeq · 4.8 · 55 other symptoms indicating multi-organ involvement. Time to onset was typically 10-14 days for both abacavir
Eintrag öffnenTriumeq · 4.8 · Abacavir hypersensitivity The signs and symptoms of this HSR are listed below. These have been identified eith
Eintrag öffnenTriumeq · 4.8 · Abacavir hypersensitivity The signs and symptoms of this HSR are listed below. These have been identified eith
Eintrag öffnenTriumeq · 4.8 · Hypersensitivity reactions Both abacavir and dolutegravir are associated with a risk for hypersensitivity reac
Eintrag öffnen